RSS-Feed abonnieren
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0041-1736542
Practice Patterns for the Acceptance of Medically Complex Living Kidney Donors with Hematuria, Sickle Cell Trait, Smoking, Illegal Drug Use, or Urological Issues: A Multinational Survey
Funding None![](https://www.thieme-connect.de/media/10.1055-s-00051312/202104/lookinside/thumbnails/10-1055-s-0041-1736542_210005-1.jpg)
Abstract
Background To review the practice patterns for the acceptance of medically complex living kidney donors (MCLKD) among the transplant providers of the international transplant community.
Methods We distributed a survey globally, through major international transplantation societies, among nephrologists and transplant surgeons (TS). The survey contained questions regarding potential donors with microscopic hematuria, sickle cell trait, renal cysts, kidney stones, smoking, or illegal drug use.
Results There were 239 respondents from 29 countries, including nephrologists (42%) and TS (58%). Although most respondents would investigate microscopic hematuria, one-third of them indicated they would decline these potential donors without investigation. Interestingly, most respondents accepted heavy smokers, intermittent illegal drug users (with advice to quit), and those with incidentally identified kidney stones, remote history of renal colic or simple renal cysts. We found multiple areas of consensus in practice with some interesting differences between nephrologists and TS.
Conclusions This survey highlights the practice patterns of the acceptance of MCLKDs among the international community. In the absence of clear guidelines, this survey provides additional information to counsel kidney donors with microscopic hematuria, sickle cell trait, renal cysts, kidney stones, heavy smoking, or illegal drug use.
Keywords
Drug Use - Extended criteria - Hematuria - kidney stone - Living kidney donor - Multi-national survey - renal cyst - sickle cell trait - smoking - SurveyPublikationsverlauf
Artikel online veröffentlicht:
15. November 2021
© 2021. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Maggiore U, Cravedi P. The marginal kidney donor. Curr Opin Organ Transplant 2014; 19 (04) 372-380
- 2 Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 2008; 8 (10) 2062-2070
- 3 Maggiore U, Budde K, Heemann U. et al; ERA-EDTA DESCARTES working group. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group. Nephrol Dial Transplant 2017; 32 (02) 216-223
- 4 Muzaale AD, Massie AB, Wang M-C. et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311 (06) 579-586
- 5 Halverson CME, Wang JY, Poulson M, Karlin J, Crowley-Matoka M, Ross LF. Living kidney donors who develop kidney failure: excerpts of their thoughts. Am J Nephrol 2016; 43 (06) 389-396
- 6 Kiberd BA, Tennankore KK. Lifetime risks of kidney donation: a medical decision analysis. BMJ Open 2017; 7 (08) e016490
- 7 Abramowicz D, Cochat P, Claas FHJ. et al. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant 2013; 28 (Suppl. 02) ii1-ii71
- 8 Lentine KL, Kasiske BL, Levey AS. et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 2017; 101 (8S): (Suppl. 01) S1-S109
- 9 Abramowicz D, Cochat P, Claas FHJ. et al. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant 2015; 30 (11) 1790-1797
-
10
ESRD Risk Tool for Kidney Donor Candidates.
Accessed September 21, 2021 at: http://wwwtransplantmodelscom/esrdrisk/
- 11 Grams ME, Sang Y, Levey AS. et al; Chronic Kidney Disease Prognosis Consortium. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 2016; 374 (05) 411-421
- 12 Cantarelli C, Cravedi P. Criteria for living donation from marginal donors: one, no one, and one hundred thousand. Nephron 2019; 142 (03) 227-232
- 13 Lafranca JA, Spoon EQW, van de Wetering J, IJzermans JNM, Dor FJMF. Attitudes among transplant professionals regarding shifting paradigms in eligibility criteria for live kidney donation. PLoS One 2017; 12 (07) e0181846
- 14 Prevention CfDCa. Incidence of Sickle Cell Trait in the US. Accessed April 13, 2020 at: https://wwwcdcgov/ncbddd/sicklecell/features/keyfinding-traithtml
- 15 Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med 2011; 31 (03) 289-293
- 16 Adam MA, Adam NK, Mohamed BA. Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan. BMC Res Notes 2019; 12 (01) 659
- 17 Shabbir S, Nadeem M, Sattar A. et al. Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan. Cogent Med 2016; 3 (01) 1188875
- 18 Piel FB, Patil AP, Howes RE. et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 2010; 1 (01) 104
- 19 Hashmi NK, Moiz B, Nusrat M, Hashmi MR. Chromatographic analysis of Hb S for the diagnosis of various sickle cell disorders in Pakistan. Ann Hematol 2008; 87 (08) 639-645
- 20 Garg AX, Levey AS, Kasiske BL, Cheung M, Lentine KL. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors Work Group and Evidence Review Team. Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice. Clin J Am Soc Nephrol 2020; 15 (06) 896-905
- 21 Kido R, Shibagaki Y, Iwadoh K. et al. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am J Transplant 2010; 10 (07) 1597-1604
- 22 Hassan EA, Ali TZ, Abdulbaki A, Ibrahim IA, Almanae HM, Aleid HA. Histopathologic findings of potential kidney donors with asymptomatic microscopic hematuria: impact on donation. Transplant Proc 2017; 49 (08) 1729-1732
- 23 Choi SR, Sun IO, Hong YA. et al. The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities. Transplant Proc 2012; 44 (01) 11-13
- 24 Kumar V, Saha M, Hanaway M, Locke J, Julian B, Gaston R. Very low levels of microscopic hematuria in potential living kidney donors is associated with pathology that precludes donation. Transplantation 2018; 102: S138
- 25 Vadivel N, Stankovic A, Rennke HG, Singh AK. Accepting prospective kidney donors with asymptomatic urinary abnormalities: are we shooting in the dark?. Kidney Int 2007; 71 (02) 173-177
- 26 Imafuku A, Nozu K, Sawa N, Nakanishi K, Ubara Y. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists. Clin Exp Nephrol 2020; 24 (08) 651-656
- 27 Choi C, Ahn S, Min SK. et al. Midterm outcome of kidney transplantation from donors with thin basement membrane nephropathy. Transplantation 2018; 102 (04) e180-e184
- 28 Carasi C, Van't Hoff WG, Rees L, Risdon RA, Trompeter RS, Dillon MJ. Childhood thin GBM disease: review of 22 children with family studies and long-term follow-up. Pediatr Nephrol 2005; 20 (08) 1098-1105
- 29 Hartono C. Live Kidney Donors with Microscopic Hematuria. The Living Donor Community of Practice of AST. Accessed September 21, 2021 at: https://www.myast.org/sites/default/files/pdf/Chapter%208%20%20Microscopic%20hematuria%20in%20kidney%20donors.pdf
- 30 Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med 2009; 122 (06) 507-512
- 31 Sesso R, Almeida MA, Figueiredo MS, Bordin JO. Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res 1998; 31 (10) 1257-1262
- 32 Beckermann KE, Sharma D, Chaturvedi S. et al. Renal medullary carcinoma: establishing standards in practice. J Oncol Pract 2017; 13 (07) 414-421
- 33 Shaw C, Sharpe CC. Could sickle cell trait be a predisposing risk factor for CKD?. Nephrol Dial Transplant 2010; 25 (08) 2403-2405
- 34 Mukendi K, Lepira FB, Makulo JR, Sumaili KE, Kayembe PK, Nseka MN. Sickle cell trait is not associated with chronic kidney disease in adult Congolese patients: a clinic-based, cross-sectional study. Cardiovasc J Afr 2015; 26 (03) 125-129
- 35 Derebail VK, Nachman PH, Key NS, Ansede H, Falk RJ, Kshirsagar AV. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol 2010; 21 (03) 413-417
- 36 Olaniran KO, Allegretti AS, Zhao SH. et al. Kidney function decline among black patients with sickle cell trait and sickle cell disease: an observational cohort study. J Am Soc Nephrol 2020; 31 (02) 393-404
- 37 Nath KA, Vercellotti GM. Renal functional decline in sickle cell disease and trait. J Am Soc Nephrol 2020; 31 (02) 236-238
- 38 Reese PP, Hoo AC, Magee CC. Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers. Transpl Int 2008; 21 (04) 328-331
- 39 Kitchlu A, Adhikari N, Burns KEA. et al. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study. BMC Nephrol 2015; 16: 127-127
- 40 Wilson D, Wakefield M, Owen N, Roberts L. Characteristics of heavy smokers. Prev Med 1992; 21 (03) 311-319
- 41 Killen JD, Fortmann SP, Telch MJ, Newman B. Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA 1988; 260 (11) 1581-1585
- 42 Aref A, Sharma A, Halawa A. Smoking in Renal Transplantation; Facts Beyond Myth. World J Transplant 2017; 7 (02) 129-133
- 43 Heldt J, Torrey R, Han D. et al. Donor smoking negatively affects donor and recipient renal function following living donor nephrectomy. Adv Urol 2011; 2011: 929263-929263
- 44 Underwood PW, Sheetz KH, Cron DC, Terjimanian MN, Englesbe MJ, Waits SA. Cigarette smoking in living kidney donors: donor and recipient outcomes. Clin Transplant 2014; 28 (04) 419-422
- 45 Donor Selection Criteria. UC Davis Health/ Transplant Center/ Living Donation. Accessed April 27, 2020 at: https://health.ucdavis.edu/transplant/livingdonation/donor_criteria.html
- 46 Ruckle D, Keheila M, West B. et al. Should donors who have used marijuana be considered candidates for living kidney donation?. Clin Kidney J 2018; 12 (03) 437-442
- 47 Lin SJ, Koford JK, Baird BC. et al. Effect of donors' intravenous drug use, cigarette smoking, and alcohol dependence on kidney transplant outcome. Transplantation 2005; 80 (04) 482-486
- 48 Piccoli GB, Soragna G, Putaggio S. et al. Drug use and kidney donation: what are high-risk behaviors today?. Transplant Proc 2006; 38 (05) 1221-1223
- 49 Grotemeyer D, Voiculescu A, Iskandar F. et al. Renal cysts in living donor kidney transplantation: long-term follow-up in 25 patients. Transplant Proc 2009; 41 (10) 4047-4051
- 50 Simms RJ, Ong AC. How simple are 'simple renal cysts'?. Nephrol Dial Transplant 2014; 29 (Suppl. 04) iv106-iv112
- 51 Lorenz EC, Lieske JC, Vrtiska TJ. et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 2011; 26 (08) 2695-2700
- 52 Tatapudi VS, Goldfarb DS. Differences in national and international guidelines regarding use of kidney stone formers as living kidney donors. Curr Opin Nephrol Hypertens 2019; 28 (02) 140-147
- 53 Serur D, Charlton M, Juluru K. et al. Long term follow up of kidney donors with asymptomatic renal stones. Nephrology (Carlton) 2017; 22 (08) 649-651
- 54 Serur D. Should kidney donors with asymptomatic small stones be allowed to donate?. Living Donor Community of Practice of AST. Accessed September 21, 2021 at: https://www.myast.org/sites/default/files/pdf/Chapter%206%20%20%20Donors%20with%20stones.pdf
- 55 Delmonico F. Council of the Transplantation Society. A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation 2005; 79 (6, Suppl) S53-S66
- 56 Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. The evaluation of living renal transplant donors: clinical practice guidelines. J Am Soc Nephrol 1996; 7 (11) 2288-2313
- 57 (OPTN) OPaTN. Organ Procurement and Transplantation Network (OPTN) Policies. Accessed April 12, 2020 at: https://optntransplanthrsagov/media/1200/optn_policiespdf#nameddest=Policy_14
- 58 MD CbQ. Predict risk of recurrent kidney stones. Accessed September 21, 2021 at: https://qxmd.com/calculate/calculator_3/roks-recurrence-of-kidney-stone-2014
- 59 Shokeir AA, Gad HM, el-Diasty T. Role of radioisotope renal scans in the choice of nephrectomy side in live kidney donors. J Urol 2003; 170 (2 Pt 1): 373-376
- 60 Oh CK, Yoon SN, Lee BM. et al. Routine screening for the functional asymmetry of potential kidney donors. Transplant Proc 2006; 38 (07) 1971-1973
- 61 Habbous S, Woo J, Lam NN. et al. The efficiency of evaluating candidates for living kidney donation: a scoping review. Transplant Direct 2018; 4 (10) e394-e394
- 62 Habbous S, Garcia-Ochoa C, Brahm G, Nguan C, Garg AX. Can split renal volume assessment by computed tomography replace nuclear split renal function in living kidney donor evaluations? A systematic review and meta-analysis. Can J Kidney Health Dis 2019; 6: 2054358119875459
- 63 Tanriover B, Fernandez S, Campenot ES. et al. Live donor renal anatomic asymmetry and posttransplant renal function. Transplantation 2015; 99 (08) e66-e74
- 64 Wright L, Faith K, Richardson R, Grant D. Joint Centre for Bioethics, University of Toronto, Toronto, Ont. Ethical guidelines for the evaluation of living organ donors. Can J Surg 2004; 47 (06) 408-413
- 65 Searing L. The Big Number: 39,717 organ transplants in the U.S. last year. Accessed March 2, 2020 at: https://wwwwashingtonpostcom/health/the-big-number-39717-organ-transplants-in-the-us-last-year/2020/02/28/2f9c376e-5976-11ea-9000-f3cffee23036_storyhtml
- 66 Organisation TSNT. World Transplant Registry reports 139,024 transplants performed worldwide last year, up 2.3%. Accessed June 24, 2020 at: https://wwwlamoncloagobes/lang/en/gobierno/news/Paginas/2019/20180828transplantaspx#:~:text=In%20total%2C%203%2C313%20kidney%20transplants,six%20intestinal%20transplants%20were%20performed